Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PROTAC technology: From drug development to probe technology for target deconvolution
Si Yan, Guangshuai Zhang, Wei Luo, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116725-116725
Closed Access | Times Cited: 10

Showing 10 citing articles:

Exploration of the Tunability of BRD4 Degradation by DCAF16 Trans-labelling Covalent Glues
Muhammad Murtaza Hassan, Yen-Der Li, W Michelle, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116904-116904
Open Access | Times Cited: 6
Prediction of Proteolysis-Targeting Chimeras Retention Time Using XGBoost Model Incorporated with Chromatographic Conditions
Xinhao Qu, Chen Jiang, Mengyi Shan, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access
Leveraging Single-Cell Multi-Omics to Decode Tumor Microenvironment Diversity and Therapeutic Resistance
Hussein Sabit, Borros Arneth, Timothy M. Pawlik, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 75-75
Open Access
HGS Promotes Tumor Growth, Whereas the Coiled-Coil Domain and Its Oligopeptide of HGS Suppress It
Kiyoshi Ogura, Ikuo Kawashima, Kohji Kasahara
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 772-772
Open Access
PROTACs coupled with oligonucleotides to tackle the undruggable
Guangshuai Zhang, Si Yan, Yan Liu, et al.
Bioanalysis (2025), pp. 1-16
Closed Access
A Comprehensive Overview of Protacs Targeting Hsp90 and Their Client Proteins for Cancer Therapy
Gulshan Kumar, Gouri Tyagi, Vikramdeep Monga
(2025)
Closed Access
Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression
Renqi Xu, Haibin Zhou, Longchuan Bai, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 20495-20513
Closed Access
Next-Generation Cancer Therapeutics: PROTACs and the Role of Heterocyclic Warheads in Targeting Resistance
Effat Omar, Rajendiran Rajesh, Pronoy Kanti Das, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117034-117034
Closed Access
Precision-engineered PROTACs minimize off-tissue effects in cancer therapy
Jianghua Shi, Luo Wang, Xuanwei Zeng, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Copper- and Iron-Based Nanoflowers in Cancer Theranostics
Agathi Vlachou, Despina A. Gkika, Pavlos Efthymiopoulos, et al.
Applied Sciences (2024) Vol. 14, Iss. 23, pp. 11294-11294
Open Access
The Role of Curcumin in Preventing Naturally Occurring Leiomyoma in the Galline Model
Kazım Şahin, Cemal Orhan, Mehmet Tuzcu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1732-1732
Open Access
Recent Advances in Developing Targeted Protein Degraders
Binbin Cheng, Hongqiao Li, Xiaopeng Peng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117212-117212
Closed Access
Page 1

Scroll to top